UPDATE

Regeneron thanks Abec for helping it avoid "gremlins" during bio plant set-up

By Gareth Macdonald contact

- Last updated on GMT

Regeneron thanks Abec
Regeneron thanks Abec

Related tags: Vice president

Abec has completed work on Regeneron’s biologics facility in Ireland just 28 months after it was hired to kit out the repurposed computer plant.

Regeneron acquired the 400,000sq ft plant in Raheen, Limerick from computer manufacturer Dell in July 2013​ investing $300m (€265m) to convert it into a biomanufacturing site for biopharmaceuticals, including monoclonal antibodies.

US tech firm Abec – which also operates a facility in Ireland​ – was hired to provide bulk bioprocess and clean utilities, including process and equipment engineering, 3-D design, equipment manufacturing, process automation, site installation and commissioning.

Daniel Van Plew, Regeneron Executive Vice President and General Manager, commended Abec the speed with which it had completed the project.

“All large, complex engineering projects are full of twists and turns from beginning to end. Raheen was no exception, and ABEC's approach gave us the ability to navigate the gremlins we encountered along the way.”

He added that: “It's amazing to have created something this massive, this quickly, and to have done it the right way."

Speed

This was echoed by an Abec spokeswoman who told us "typically plants of this size and scope have taken at least 48 months, often longer, to achieve licensure.​"

She added that: "Gremlins refers to the typical challenges you see with projects of this size and scope, such as scope clarity and accountability, component supply chain issues, construction site coordination, and management of change. 

“ABEC’s Integrated Solution dramatically improves the customer’s ability to address these challenges."​ 

Related news

Show more

Related products

Microsampling in Early Phase Drug Development

Microsampling in Early Phase Drug Development

Altasciences | 10-May-2022 | Technical / White Paper

Microsampling significantly lessens the volume of blood and plasma/serum that is collected and analyzed to determine circulating concentrations of therapeutic...

Seasonal Vaccine Manufacturing

Seasonal Vaccine Manufacturing

Baxter BioPharma Solutions | 16-Feb-2022 | Technical / White Paper

The production of seasonal vaccines, such as those for influenza, presents unique challenges to manufacturers due to the necessary time constraints resulting...

Consideration and Options for Prefilled Syringes

Consideration and Options for Prefilled Syringes

Baxter BioPharma Solutions | 16-Feb-2022 | Technical / White Paper

Convenience, product differentiation, and less waste are great reasons for developing a product in a prefilled syringe. Baxter’s whitepaper describes the...

Partner with Experts in Precision Medicine

Partner with Experts in Precision Medicine

CellCarta | 17-Jan-2022 | Product Brochure

At CellCarta, we’re dedicated to working with our partners to further the limitless potential of precision medicine. Our broad technology offering is designed...

Related suppliers

Follow us

Products

View more

Webinars